作者: Amanda B. Hummon , Steven Buechler
DOI:
关键词:
摘要: Genetic biomarkers for left side colon cancer (LCC) (such as expression levels of an RNA transcript or product NOX4, MMP3, a combination) and right (RCC) CDCX2, FAM69A, combination), are disclosed. Methods using the in providing prognosis relapse-free survival probability patients having LCC RCC also presented. Prognostic panels gene values Computer implemented methods employing biomarkers, well determining patient provided. A genetic method classifying tissue is